Clinical Trials
188 trialsCAR-T Followed by Bispecific Antibodies
Abramson Cancer Center at Penn Medicine
CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Stanford University
SPiReL
Sunnybrook Health Sciences Centre
Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP
Ruijin Hospital
A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping
Ruijin Hospital
Glofitamab in Chinese Patients With R/R DLBCL
Peking Union Medical College Hospital
Pembrolizumab in Neoplasms or Lymphomas
Dana-Farber Cancer Institute
Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL
The First Affiliated Hospital with Nanjing Medical University
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Virginia Commonwealth University
Glofitamab Combined With CAR-T Therapy in R/R DLBCL
Ruijin Hospital
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
H. Lee Moffitt Cancer Center and Research Institute
ODIN
University Health Network, Toronto
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
The First Affiliated Hospital of Soochow University
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
University of Arizona
Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Memorial Sloan Kettering Cancer Center
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
University of Nebraska
BEB
Insel Gruppe AG, University Hospital Bern
FERTILE
The Lymphoma Academic Research Organisation
ImmunoMRI for Assessment of Tumor-associated Macrophages
Medical University of Vienna
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Florida International University
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Ain Shams University
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Masonic Cancer Center, University of Minnesota
A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1
Institute of Hematology & Blood Diseases Hospital, China
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
City of Hope Medical Center
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
Masonic Cancer Center, University of Minnesota
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
The First Affiliated Hospital with Nanjing Medical University
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
The First Affiliated Hospital of Xiamen University
AZA Combined With RCHOP in P53-mutated DLBCL.
The First Affiliated Hospital of Xiamen University
POSS
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Dragon
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Real-World Study of DLBCL With Different Genetic Subtypes
Ruijin Hospital
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
Université de Sherbrooke
HOVON161
University Medical Center Groningen
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Zhejiang Provincial People's Hospital
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
University Medical Center Goettingen
LNH012
Gruppo Italiano Malattie EMatologiche dell'Adulto
Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Australasian Leukaemia and Lymphoma Group
CD30 Imaging in Diffuse Large B-cell Lymphoma
University Medical Center Groningen
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Florida International University
Relyage
Centre Hospitalier Universitaire, Amiens
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Case Comprehensive Cancer Center
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Roswell Park Cancer Institute
DLBCL
Rush University Medical Center